How does semaglutide work?
It activates GLP-1 receptors involved in appetite and satiety, which may help eligible patients manage food intake as part of a supervised treatment plan.
Personalized, medically supervised weight management designed around your health and goals.

Learn about a clinically guided approach to weight management, including evaluation, follow-up and ongoing support.
SCHEDULE A CONSULTATIONMedical weight management begins with understanding your health history, goals and treatment options. At Cosmetica Medical Clinic in Yuba City, a clinical consultation helps determine whether semaglutide may be appropriate as part of a broader weight-management plan.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It acts on pathways involved in appetite and fullness. Certain FDA-approved semaglutide products are indicated for chronic weight management in eligible patients alongside reduced-calorie eating and increased physical activity; eligibility and the specific product matter.
A licensed clinician reviews your medical history, current medications, weight-related health factors and treatment goals. Semaglutide is not suitable for everyone. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should not use semaglutide products that carry this contraindication.
Your provider will explain whether treatment is appropriate, how the prescribed product is administered, how follow-up is managed and what lifestyle changes may support your goals. Dosing and treatment duration are individualized and must follow the prescribing clinician’s instructions. Weight-loss results vary.
Common side effects can include nausea, vomiting, diarrhea, constipation and abdominal discomfort. More serious concerns may include pancreatitis, gallbladder problems, dehydration-related kidney injury and severe allergic reactions. Tell your clinician about all medicines, health conditions and any plans for pregnancy. Semaglutide should not be used during pregnancy for weight loss.
Medical supervision helps clarify product selection, eligibility, safety precautions and follow-up. If a compounded preparation is discussed, ask your provider about its regulatory status and risks: compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality before marketing.
← EXPLORE WELLNESS & CONSULTATIONSIt activates GLP-1 receptors involved in appetite and satiety, which may help eligible patients manage food intake as part of a supervised treatment plan.
Results vary by individual, prescribed product, treatment adherence and lifestyle factors. Your clinician can discuss realistic goals and follow-up.
Yes. A clinical assessment is important to review your health history, medications, contraindications and whether treatment is appropriate.
Digestive symptoms such as nausea, constipation and diarrhea are common. Your provider will review other important risks and symptoms that need prompt attention.
Semaglutide should not be used for weight loss during pregnancy. Tell your provider if you are pregnant, planning pregnancy or breastfeeding.
No. Nutrition, physical activity and appropriate follow-up remain important components of medically supervised weight management.
Interested in exploring medical weight-loss options?
BOOK A CONSULTATION